{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:09 23:24:50.411",
            "Expression": "NCT00790413",
            "NStudiesAvail": 430269,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "PrimaryOutcomeTimeFrame",
                  "ReferenceCitation",
                  "ReferencePMID",
                  "ReferenceType",
                  "RemovedCountry",
                  "ResponsiblePartyInvestigatorAffiliation",
                  "ResponsiblePartyInvestigatorFullName",
                  "ResponsiblePartyInvestigatorTitle",
                  "ResponsiblePartyOldNameTitle",
                  "ResponsiblePartyOldOrganization",
                  "ResponsiblePartyType",
                  "ResultsFirstPostDate",
                  "ResultsFirstPostDateType",
                  "ResultsFirstPostedQCCommentsDate",
                  "ResultsFirstPostedQCCommentsDateType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "PrimaryOutcomeTimeFrame": [
                              "day 100"
                        ],
                        "ReferenceCitation": [
                              "Inoue M, Nakano T, Yoneda A, Nishikawa M, Nakayama M, Yumura-Yagi K, Sakata N, Yasui M, Okamura T, Kawa K. Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation. Bone Marrow Transplant. 2003 Jul;32(1):103-6.",
                              "Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol. 2006 Jan 20;24(3):500-6.",
                              "Prigione I, Corrias MV, Airoldi I, Raffaghello L, Morandi F, Bocca P, Cocco C, Ferrone S, Pistoia V. Immunogenicity of human neuroblastoma. Ann N Y Acad Sci. 2004 Dec;1028:69-80. Review.",
                              "Neal ZC, Imboden M, Rakhmilevich AL, Kim KM, Hank JA, Surfus J, Dixon JR, Lode HN, Reisfeld RA, Gillies SD, Sondel PM. NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunol Immunother. 2004 Jan;53(1):41-52. Epub 2003 Sep 18.",
                              "Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene. 2005 Jul 7;24(29):4634-44.",
                              "Lang P, Pfeiffer M, M\u00fcller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, F\u00f6ll J, Martin D, Handgretinger R. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects. Klin Padiatr. 2006 Nov-Dec;218(6):321-6.",
                              "Toporski J, Garkavij M, Tennvall J, Ora I, Gleisner KS, Dykes JH, Lenhoff S, Juliusson G, Scheding S, Turkiewicz D, B\u00e9k\u00e1ssy AN. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma. Biol Blood Marrow Transplant. 2009 Sep;15(9):1077-85. doi: 10.1016/j.bbmt.2009.05.007. Epub 2009 Jul 8.",
                              "Illhardt T, Toporski J, Feuchtinger T, Turkiewicz D, Teltschik HM, Ebinger M, Schwarze CP, Holzer U, Lode HN, Albert MH, Gruhn B, Urban C, Dykes JH, Teuffel O, Schumm M, Handgretinger R, Lang P. Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma. Biol Blood Marrow Transplant. 2018 May;24(5):1005-1012. doi: 10.1016/j.bbmt.2017.12.805. Epub 2018 Jan 4."
                        ],
                        "ReferencePMID": [
                              "12815485",
                              "16421427",
                              "15650233",
                              "14504825",
                              "15897905",
                              "17080334",
                              "19660720",
                              "29307718"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background",
                              "background",
                              "background",
                              "background",
                              "result",
                              "result"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [
                              "Lund University Hospital"
                        ],
                        "ResponsiblePartyInvestigatorFullName": [
                              "Jacek Toporski"
                        ],
                        "ResponsiblePartyInvestigatorTitle": [
                              "MD, PhD"
                        ],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Principal Investigator"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT00790413"
                        ]
                  }
            ]
      }
}